Tracking cancer occurrence in the 5 years after referral for suspected head and neck cancer.

Diagnostic accuracy Early diagnosis Head and neck cancer Referral Suspected cancer Teachable moment Two week wait

Journal

Oral oncology
ISSN: 1879-0593
Titre abrégé: Oral Oncol
Pays: England
ID NLM: 9709118

Informations de publication

Date de publication:
25 Aug 2020
Historique:
received: 28 02 2020
revised: 03 06 2020
accepted: 04 08 2020
pubmed: 29 8 2020
medline: 29 8 2020
entrez: 29 8 2020
Statut: aheadofprint

Résumé

Very little is known about those who receive a negative (benign) result after referral for suspected cancer, including their risk for future cancer. This service evaluation aimed to track the occurrence of cancer (of any type) in the 5 years after an appointment for suspected head and neck cancer (HNC) and compare to those referred to hospital for routine ear nose and throat reasons. Patient identifiers of referrals to one hospital Trust with either a) suspected HNC cancer on a two week wait (TWW) pathway, or b) routine ear, nose & throat problems, were linked with the National Cancer Registry data to determine the occurrence, site and stage of subsequent cancer. 10,314 patients were referred between 2009 and 2011. Cancer occurrence in the 5 years after their appointment for those who had initially received a negative diagnosis, was 4.0% for those referred via TWW and 2.1% for those routinely referred. Lung cancer was the most common subsequent cancer site in the TWW group. Those in higher age groups, those with previous cancer, and those referred via the TWW pathway were significantly more likely be diagnosed with subsequent cancer. Given the increased risk of subsequent cancer, it could be beneficial to improve the service provision (e.g. advice on screening attendance, ways to reduce risk, advice on timely help-seeking for symptoms of cancer) at the point of a negative diagnosis on the TWW pathway, especially in older patients and those with a previous diagnosis of cancer.

Identifiants

pubmed: 32858416
pii: S1368-8375(20)30391-2
doi: 10.1016/j.oraloncology.2020.104955
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104955

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

S E Scott (SE)

Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, UK. Electronic address: Suzanne.scott@kcl.ac.uk.

R Oakley (R)

Guy's & St Thomas' NHS Foundation Trust, London, UK.

H Møller (H)

The Danish Clinial Registries (RKKP), Aarhus, Denmark and Danish Centre for Clinical Health Services Research, Aalborg University, Aalborg, Denmark.

F Warburton (F)

Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, UK.

Classifications MeSH